Home
›
Aspire Biopharma Holdings, Inc.
› SCHEDULE 13G/A Mar 28, 2025
Aspire Biopharma Holdings, Inc. (ASBP): SCHEDULE 13G/A filed Mar 28, 2025
Form type
SCHEDULE 13G/A
Filing date
Mar 28, 2025
Accession number
0001641172-25-001328
Filer
Aspire Biopharma Holdings, Inc.
(CIK 1847345)